Aspergillus mutant strain and transformant thereof
    84.
    发明授权
    Aspergillus mutant strain and transformant thereof 有权
    曲霉菌突变菌株及其转化体

    公开(公告)号:US09567563B2

    公开(公告)日:2017-02-14

    申请号:US15014585

    申请日:2016-02-03

    摘要: Provided are an Aspergillus mutant strain which can dramatically enhance production of a heterologous enzyme when a saccharifying enzyme gene is transferred into the strain to perform transformation and a transformant having a saccharifying enzyme gene transferred into the Aspergillus mutant strain. The Aspergillus mutant strain has been completely or partially deficient in three genes of Aspergillus oryzae strain HO2 (accession number: NITE BP-01750): a prtR gene coding for a transcription factor; a pepA gene coding for an extracellular acid protease; and a cpI gene coding for an extracellular acid carboxypeptidase.

    摘要翻译: 提供了当将糖化酶基因转移到菌株进行转化时,可以显着提高异源酶的产生的曲霉菌突变菌株和将糖化酶基因转移到曲霉菌突变株中的转化体。 曲霉菌突变菌株在米曲霉菌株HO2(登录号:NITE BP-01750)的三个基因中完全或部分缺陷:编码转录因子的prtR基因; 编码细胞外酸性蛋白酶的pepA基因; 和编码细胞外酸羧肽酶的cpI基因。

    Lipase variants for pharmaceutical use
    85.
    发明授权
    Lipase variants for pharmaceutical use 有权
    用于药物用途的脂肪酶变体

    公开(公告)号:US09539311B2

    公开(公告)日:2017-01-10

    申请号:US14679563

    申请日:2015-04-06

    摘要: The pharmaceutical use of lipases related to the Thermomyces lanuginosus (Humicola lanuginosa) lipase comprising amino acids 1-269 of SEQ ID NO: 2, optionally in combination with a protease and/or an amylase. Examples of medical indications are: Treatment of digestive disorders, pancreatic exocrine insufficiency (PEI), pancreatitis, cystic fibrosis, diabetes type I, and/or diabetes type II. The lipases of the invention have, e.g., an improved digestion performance in vitro, an improved activity at a pH in the neutral range, an improved stability at low pH, an are stable against protease-degradation, and/or are stable in the presence of pepsin and bile salts. The invention also relates to methods of determining digestion performance in vitro of lipases, as well as to certain novel variants of the lipase of T. lanuginosus.

    摘要翻译: 与包含SEQ ID NO:2的氨基酸1-269的Thermomyces lanuginosus(Humicola lanuginosa)脂肪酶相关的脂肪酶的药物用途,任选地与蛋白酶和/或淀粉酶组合。 医学适应症的例子有:消化系统疾病,胰腺外分泌功能不全(PEI),胰腺炎,囊性纤维化,I型糖尿病和/或II型糖尿病的治疗。 本发明的脂肪酶具有例如体外改进的消化性能,在中性范围内的pH值改善的活性,在低pH下的改进的稳定性,对蛋白酶降解是稳定的,和/或在存在时是稳定的 的胃蛋白酶和胆汁盐。 本发明还涉及确定脂肪酶的体外消化性能的方法以及T.lanuginosus的脂肪酶的某些新颖变体。

    Granzyme B protease variants
    87.
    发明授权
    Granzyme B protease variants 有权
    粒酶B蛋白酶变体

    公开(公告)号:US09528101B2

    公开(公告)日:2016-12-27

    申请号:US14346600

    申请日:2012-09-21

    申请人: PHARMEDARTIS GMBH

    IPC分类号: C12N9/48 C12N9/64 A61K47/48

    摘要: The present disclosure provides novel variants of enzymes exhibiting serine protease activity; nucleic acid molecules encoding said proteases, vectors, host cells containing the nucleic acids and methods for preparation and producing such enzymes; compositions and complexes comprising at least one of the proteases; and methods for using such enzymes as a part of an immunoprotease, in particular for the treatment of cancer.

    摘要翻译: 本公开提供了显示丝氨酸蛋白酶活性的酶的新型变体; 编码所述蛋白酶,载体,含有核酸的宿主细胞的核酸分子以及制备和产生此类酶的方法; 包含至少一种蛋白酶的组合物和复合物; 以及使用这些酶作为免疫蛋白酶的一部分的方法,特别是用于治疗癌症的方法。

    Method for secretory production of protein
    89.
    发明授权
    Method for secretory production of protein 有权
    蛋白质分泌生产方法

    公开(公告)号:US09404138B2

    公开(公告)日:2016-08-02

    申请号:US14264600

    申请日:2014-04-29

    摘要: A novel technique for improving ability for secretory production of a multimeric protein of a coryneform bacterium is provided, and thereby a method for secretory production of a multimeric protein is provided. A multimeric protein is produced by secretory production utilizing a coryneform bacterium having an ability to produce a multimeric protein by secretory production and modified so that expression of a gene coding for a metallopeptidase is increased as an expression host.

    摘要翻译: 提供了一种用于提高棒状细菌多聚体蛋白质分泌生产能力的新技术,从而提供了一种多聚体蛋白质的分泌生产方法。 通过使用具有通过分泌生产产生多聚体蛋白质的能力的棒状细菌进行分泌生产来产生多聚体蛋白质并进行修饰,以使编码金属肽酶的基因的表达作为表达宿主增加。

    Polypeptides having carboxypeptidase activity and polynucleotides encoding same
    90.
    发明授权
    Polypeptides having carboxypeptidase activity and polynucleotides encoding same 有权
    具有羧肽酶活性的多肽和编码该多肽的多核苷酸

    公开(公告)号:US09399769B2

    公开(公告)日:2016-07-26

    申请号:US14104809

    申请日:2013-12-12

    申请人: Novozymes, Inc.

    发明人: Michael Rey

    摘要: The present invention relates to isolated polypeptides having carboxypeptidase activity and isolated polynucleotides encoding the polypeptides. The invention also relates to nucleic acid constructs, vectors, and host cells comprising the polynucleotides as well as methods of producing and using the polypeptides.

    摘要翻译: 本发明涉及具有羧肽酶活性的分离的多肽和编码多肽的分离的多核苷酸。 本发明还涉及包含多核苷酸的核酸构建体,载体和宿主细胞以及产生和使用多肽的方法。